RegASK: Unlocking Faster Market Access and Compliance Confidence with AI-Driven Regulatory Intelligence
What is RegASK? RegASK is an AI-powered regulatory intelligence platform designed to streamline and enhance regulatory compliance processes within the life sciences industry. It uses natural language processing (NLP) and machine learning to automatically extract, analyse, and summarise regulatory documents, guidelines, and global health authority requirements. This enables companies to stay up-to-date with ever-changing regulations […]
Feature Categories
What is RegASK?
RegASK is an AI-powered regulatory intelligence platform designed to streamline and enhance regulatory compliance processes within the life sciences industry. It uses natural language processing (NLP) and machine learning to automatically extract, analyse, and summarise regulatory documents, guidelines, and global health authority requirements.
This enables companies to stay up-to-date with ever-changing regulations efficiently and reduces manual workload and risks of non-compliance. Use cases include regulatory strategy planning, submissions management, risk assessment, and accelerated market access through intelligent insights and alerts.
RegASK supports proactive decision-making by providing real-time regulatory updates, making it a valuable tool for regulatory affairs teams, compliance officers, and life sciences executives.
RegASK has also made significant product advances in 2024-2025, particularly around their RegGenius platform (agentic AI for workflow automation) and vertical LLM technology.
Why Leading Healthcare Teams Trust RegASK
-
AI-Driven Regulatory Intelligence Platform
RegASK offers an AI-powered platform that combines machine learning algorithms with a global network of regulatory experts to provide accurate, actionable, and timely insights, streamlining compliance processes and mitigating risks. -
World’s First Agentic AI for Regulatory Affairs
RegASK has launched the first agentic AI architecture purpose-built for regulatory intelligence, integrating vertical large language models (LLMs) with autonomous agent capabilities to accelerate regulatory compliance and enhance accuracy. -
Comprehensive Regulatory Insights Across Industries
RegASK provides tailored regulatory intelligence solutions across various industries, including Life Sciences, Pharma & Biotech, Medical Devices, Food & Beverages, Personal Care & Cosmetics, and Animal Care, ensuring relevant and actionable information for businesses of all sizes. -
Proven Success in Global Regulatory Compliance
RegASK has assisted numerous companies in achieving global regulatory compliance, as demonstrated in various case studies. For instance, they helped an infant formula manufacturer expand into new markets by providing expert guidance on regulatory requirements. -
Real-Time Monitoring and Alerts
The RegAlerts feature allows organizations to proactively monitor and track changes in regulations specific to their business scope, providing customized alerts, summarized regulatory updates, and impact analysis to identify potential compliance risks. -
Collaborative Workflow Management
RegASK's platform includes a powerful task management system that transforms regulatory workflows, enabling seamless collaboration among team members and stakeholders, ensuring efficient management of every aspect of the regulatory process
Top 3 Pain Points RegAsk Fixes in Healthcare
| Top Problems Solved by RegAsk | Description |
|---|---|
| 1. Regulatory Complexity & Compliance Risks | Automates monitoring and interpretation of evolving global regulations to minimize compliance risks and avoid costly delays. |
| 2. Manual, Time-Consuming Regulatory Research | Uses AI to extract and summarize relevant regulatory information quickly, reducing the time and effort needed for manual research. |
| 3. Fragmented Regulatory Intelligence & Data Silos | Centralizes regulatory data and insights in one platform, improving accessibility, collaboration, and informed decision-making. |
Feature Category Summary: RegASK
| Feature Category | Summary | Association (YES, NO, NA) |
|---|---|---|
| Regulatory-Ready | RegASK is positioned as an AI-driven regulatory intelligence and risk‑management platform that automates monitoring of global regulations, generates triaged alerts, and orchestrates end‑to‑end regulatory workflows, providing “audit‑ready insights in seconds” via its Action Hub command center and RegAlerts capabilities. Security and compliance FAQs state that RegASK is GDPR‑compliant, ISO 27001 and SOC 2 Type 2 certified, with encrypted data, RBAC, SSO, and extensive admin/data‑access logs with immutable audit trails, and for life‑science clients it “aligns with GxP and other relevant industry‑specific security frameworks where applicable,” which indicates support for regulated workflows and auditability even though formal FDA/EMA software validation is not explicitly documented. | YES |
| Clinical Trial Support | RegASK is framed as a regulatory‑intelligence and workflow platform for life‑science and CPG products, with use cases including regulatory strategy, submissions, risk assessment, and market‑access planning. RegGenius (the regulatory copilot) can answer questions such as “What are the clinical trial regulations in Europe?” and “What guidelines do I need to follow for quality control?” by searching curated, validated regulatory content, but there is no indication that the platform directly supports patient recruitment, protocol optimization, site selection, or clinical data monitoring; its role is regulatory guidance around trials rather than operational trial execution. “No public documentation found” for dedicated clinical‑trial design, recruitment, or monitoring modules. | NA |
| Supply Chain & Quality | Public materials describe RegASK as centralizing regulatory intelligence, mapping requirements to products and markets, and providing impact analysis and workflows for compliance actions across the product lifecycle in sectors including pharma, biotech, medical devices, food, and cosmetics. While regulatory content may encompass quality and GMP expectations, the platform is not described as a supply‑chain QA or manufacturing execution system, and there is no documentation of features like batch‑level QA tracking, serialization, or counterfeit detection; it focuses on regulatory text and compliance workflows, not operational quality‑control automation. “No public documentation found” for explicit supply‑chain or manufacturing‑quality functionality. | NA |
| Efficiency & Cost-Saving | RegASK cites a case where a UK‑based clinical research site achieved a 40% increase in operational efficiency and a 50% decrease in manual monitoring time by using the platform, reflecting automation of regulatory tracking and decision support. The RegGenius copilot and Action Hub command center automate alert creation, impact assessment, task triggering, and documentation generation using agentic AI and vertical LLMs, explicitly marketed as reducing manual research, eliminating external tracking spreadsheets, and transforming scattered compliance tasks into streamlined workflows with complete visibility and accountability. These are explicit claims of process automation, investigator/team time savings, and cost‑efficiency. | YES |
| Scalable / Enterprise-Grade | RegASK is described as an AI‑driven, end‑to‑end regulatory‑workflow platform used globally by life‑science and CPG organizations, enabling coverage in 150+ countries with a network of 1,700+ subject‑matter experts and rapidly growing platform adoption (10x growth noted alongside ISO 42001 certification). The security page details enterprise‑grade controls (Azure hosting, RBAC, SSO, scoped API keys, continuous monitoring, WAF, DDoS protection, pen‑testing, regional data hosting options, and audit artifacts available under NDA), indicating a SaaS architecture designed for large, multi‑market teams and enterprise deployments. | YES |
| HIPAA Compliant | RegASK’s security FAQs state the platform is GDPR‑compliant and certified to ISO 27001 and SOC 2 Type 2, with data encrypted in transit and at rest, role‑based access, and hosting on secure Microsoft Azure infrastructure, and external commentary notes frameworks including SOC 2, ISO 27001, HIPAA, and PCI DSS in the context of compliance best practices. However, the official FAQ and security pages do not clearly state that RegASK is formally “HIPAA compliant” or certified under HIPAA/HITECH, and no detailed HIPAA mapping is provided; any HIPAA mention appears in broader industry roundups rather than as an explicit vendor claim. “No public documentation found” with a definitive HIPAA‑compliance statement from RegASK itself. | NA |
| Clinically Validated | RegASK is positioned as a regulatory‑intelligence and compliance‑workflow platform, not a clinical diagnostic or therapeutic tool; documentation and case studies emphasize faster regulatory research, better compliance, and market‑access support, but do not describe prospective clinical trials, patient‑outcome studies, or regulatory device approvals validating RegASK as a clinical decision‑support or medical device product. “No public documentation found” for clinical validation in terms of therapeutic efficacy, patient outcomes, or medical‑device clearance. | NA |
| EHR Integration | RegASK’s product materials, Action Hub, and RegGenius descriptions focus on integrating curated regulatory content, organization‑specific documents (“bring your own content”), and business‑context metadata into one command center for compliance workflows. There is no mention of technical integration with EHR/EMR systems (e.g., HL7/FHIR connectors) or embedding into clinical workflows; the platform operates in the regulatory and compliance domain, not within clinical information systems. “No public documentation found” for EHR integration. | NO |
| Explainable AI | RegASK emphasizes “agentic AI” and vertical LLMs that operate on curated, validated regulatory data with business‑context metadata, and the RegGenius copilot answers questions by drawing from an organization’s approved regulatory content and scoped context, which gives users a clear view of the data sources and scope used for answers. External analyses describe RegASK’s AI as delivering explainable decision‑making for regulatory insights, and the platform’s impact‑analysis and context‑engineering features show how each alert is contextualized to specific products and markets, which amounts to transparent, traceable AI‑driven recommendations rather than opaque black‑box outputs. | YES |
| Real-Time Analytics | RegASK markets “real-time regulatory updates, alerts, and analytics dashboards” for proactive compliance monitoring, with RegAlerts enabling organizations to track regulation changes in their scope and receive customized alerts, summarized updates, and impact analyses. The Businesswire and product pages describe “near real‑time” RegGenius processing, where uploaded documents become immediately available for AI analysis, as well as continuous monitoring of global regulatory sources, demonstrating real‑time or near real‑time analytics over regulatory data streams rather than batch‑only updates. | YES |
| Bias Detection | Although RegASK uses AI and ML for regulatory text analysis and emphasizes accuracy, contextualization, and risk identification, no documentation describes features specifically aimed at algorithmic bias detection, fairness metrics, or performance analysis across demographic or clinical sub‑cohorts. The domain is regulatory content rather than patient‑level data, and bias‑detection tooling is not mentioned. “No public documentation found” for bias‑detection capabilities. | NA |
| Ethical Safeguards | RegASK maintains an “Enterprise‑Grade Security & Compliance” framework with GDPR compliance, ISO 27001 and SOC 2 Type 2 certification, encryption, RBAC/SSO, comprehensive admin and data‑access logs, and a documented incident‑response plan; the security page also notes that model usage is monitored, restricted to approved providers with documented risk assessments, and includes human‑in‑the‑loop controls as part of its Artificial Intelligence Management System (AIMS), which is certified to ISO/IEC 42001:2023 for AI governance. These elements provide explicit AI‑governance safeguards (risk‑assessed models, human‑in‑the‑loop oversight, logging, and responsible‑AI certification), although there is less detail on per‑use‑case restriction tooling or explicit consent‑management for source data; overall, there is sufficient evidence of built‑in AI governance controls and ethical‑AI management. | YES |
Risks & Limitations: RegASK
-
Predictive performance depends on dataset quality, completeness, and consistency; missing or inaccurate regulatory data can reduce reliability.
-
Outputs are decision-support only; regulatory teams must validate recommendations before submission or compliance action.
-
Integration with proprietary regulatory tracking systems, eCTD platforms, or enterprise workflows may require IT effort and configuration.
-
Regulatory or compliance review is necessary when using AI outputs to inform submissions, audits, or regulatory decision-making.
-
Model updates must be monitored for changing regulatory guidelines or country-specific requirements to maintain accuracy.
-
Limited explainability for complex regulatory predictions may require human interpretation and documentation to satisfy internal and external audits.
Share This AI Tool
